Abstract
MVIIA (ziconotide) is a specific inhibitor of N-type calcium channel, Cav2.2. It is derived from Cone snail and currently used for the treatment of severe chronic pains in patients unresponsive to opioid therapy. However, MVIIA produces severe side-effects, including dizziness, nystagmus, somnolence, abnormal gait, and ataxia, that limit its wider application. We previously identified a novel inhibitor of Cav2.2, ω-conopeptide SO-3, which possesses similar structure and analgesic activity to MVIIA's. To investigate the key residues for MVIIA toxicity, MVIIA/SO-3 hybrids and MVIIA variants carrying mutations in its loop 2 were synthesized. The substitution of MVIIA's loop 1 with the loop 1 of SO-3 resulted in significantly reduced Cav2.2 binding activity in vitro; the replacement of MVIIA loop 2 by the loop 2 of SO-3 not only enhanced the peptide/Cav2.2 binding but also decreased its toxicity on goldfish, attenuated mouse tremor symptom, spontaneous locomotor activity, and coordinated locomotion function. Further mutation analysis and molecular calculation revealed that the toxicity of MVIIA mainly arose from Met(12) in the loop 2, and this residue inserts into a hydrophobic hole (Ile(300), Phe(302) and Leu(305)) located between...Continue Reading
References
Jul 1, 1992·Neuron·D R HillyardL J Cruz
Nov 1, 1990·Pain·Z SeltzerY Shir
Apr 21, 1987·Biochemistry·B M OliveraW R Gray
Aug 15, 1995·Biochemistry·T KohnoK Sato
Jun 27, 1995·Biochemistry·L NadasdiJ Ramachandran
Nov 17, 1994·Nature·P T EllinorR W Tsien
Nov 1, 1993·Neuropharmacology·D R WitcherK P Campbell
Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
May 1, 1996·Neuropharmacology·T TabataA T Ishida
May 29, 1999·Biochemistry·K J NielsenD J Craik
Jul 20, 2002·Neuropharmacology·Kenichi KatoKenji Kitamura
Jan 1, 2003·Pain·Annika B MalmbergAllan I Basbaum
Sep 27, 2003·Journal of Natural Products·Qiuyun DaiPeitang Huang
Jun 18, 2004·Journal of Neurophysiology·Yingxin LinDiane Lipscombe
May 10, 2005·British Journal of Pharmacology·Lei WenPeitang Huang
Aug 11, 2007·Science·Isaiah T ArkinDavid E Shaw
Oct 30, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rhiju DasDavid Baker
Dec 22, 2010·Molecular Pain·Seungkyu LeeJae Il Kim
Jun 8, 2012·British Journal of Pharmacology·V Nimmrich, G Gross
Jul 26, 2012·Current Topics in Medicinal Chemistry·Irina Vetter, Richard J Lewis
Feb 6, 2013·Biochimica Et Biophysica Acta·David J Adams, Géza Berecki
May 9, 2013·Biochemistry·Rong Chen, Shin-Ho Chung
May 30, 2013·British Journal of Pharmacology·A JayamanneC W Vaughan
Sep 4, 2013·CNS Drugs·Mark Sanford
Jan 29, 2014·Neuropharmacology·Meichun Deng Songping Liang
Citations
Oct 26, 2016·Neuropharmacology·Emmanuel Bourinet, Gerald W Zamponi
Jun 14, 2017·British Journal of Pharmacology·Jeffrey R McArthurDavid J Adams
Oct 14, 2017·Marine Drugs·David RamírezIngrid Carvacho
Oct 5, 2018·PloS One·Karen M OliveiraEliane G Melo
Jan 19, 2018·Scientific Reports·Zhuguo LiuQiuyun Dai
Apr 5, 2018·Marine Drugs·Jinqin ChenQiuyun Dai
Dec 14, 2018·Toxins·Eliane DallegraveAlessandra Hubner de Souza
Mar 6, 2019·Marine Drugs·Rachael A MansbachS Gnanakaran
Aug 10, 2017·Toxins·Shuo YuQiuyun Dai
May 15, 2019·Marine Drugs·Shuo YuMingxin Dong
Feb 22, 2021·Toxicon : Official Journal of the International Society on Toxinology·Yuanyuan QiangLei Wang
Mar 21, 2021·Basic & Clinical Pharmacology & Toxicology·Yun WuMaojun Zhou
Oct 4, 2018·Biochemistry·Minxing DongQiuyun Dai
Jul 1, 2020·Journal of Medicinal Chemistry·Steve ReynaudNicolas Gilles
Oct 26, 2018·Journal of Medicinal Chemistry·Fengtao CaiQiuyun Dai
Oct 22, 2019·Chemical Reviews·Ai-Hua JinPaul F Alewood
Nov 11, 2021·Science Translational Medicine·Selwyn JayakarClifford J Woolf